Oklo's stock surged on Trump's support for nuclear power, accelerating permitting timelines, but it remains highly volatile and speculative due to its pre-revenue status and uncertain profitability.
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback